Auralab360 sp. z o.o.

Manufacture of food supplements

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2023-05-31
Share capital
500,000.00 PLN
Activity description

Auralab360 is a Polish dietary supplement manufacturer offering contract manufacturing, R&D formulation development and private-label brand support. The company manages the process from concept to finished product, including low production minimums and HACCP and GMP standards.

Registered address
ul. Zacisze 1, 05-552 Łazy, Poland
Email
Phone
Electronic delivery address
AE:PL-97349-14530-DBEAV-15

Financials

Revenue history (in k)

Filing timeliness

Financial statements were filed on time, on average 32 days early.

  • 202514/07/2026
  • 202415/07/2025
  • 202310/04/2024
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Top 35%
Division · Manufacture of food products1,910 / 3,403
Top 56%
Sector · Manufacturing11,318 / 24,548
Top 46%
City · Łazy23 / 89
Top 26%
Voivodeship · Mazowieckie19,383 / 76,892
Top 25%
Country · Poland76,550 / 297,069
Top 26%

Results vs industry

Revenue
This companyUSD 1.39mMedianUSD 284.01kAverageUSD 6.97m
Net profit
This companyUSD 52.66kMedianUSD 4.93kAverageUSD 683.78k
Operating costs
This companyUSD 1.32mMedianUSD 387.31kAverageUSD 6.05m
Assets
This companyUSD 524.08kMedianUSD 349.52kAverageUSD 6.87m

Websites

  • auralab360.plProducent suplementów diety dla Twojej marki – AuraLab360
    WordPress 6.9ElementorGoogle Tag ManagerYoast SEOLiteSpeed
  • micromeds.plmicromeds
    ShopifyCloudflare

Authorized Representatives

Karol Wojciech Sadłowski age 30 – Management Board Member
Paweł Marcin Ryćko age 42 – Management Board Member
Mateusz Tupczyński age 35 – President of the Management Board
Wiktor Mirosław Walczak age 32 – Management Board Member

Manner of representation

In the case of a one-person management board, the member of the management board makes declarations on behalf of the company. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.

Ownership

OwnerSharesShare valueStake
2,500$33,765.5325%
2,500$33,765.5325%
2,500$33,765.5325%
2,500$33,765.5325%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2023-06-12.

Debt

No entries in the National Debtors Register (KRZ).

Secured liabilities

Type
Promissory note

Public aid

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
$6,529

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Laborell sp. z o.o.
H+B Group sp. z o.o.
Biocorpo sp. z o.o.
Establo Pharma sp. z o.o.
Pharma Dot sp. z o.o.
Fitmax sp. z o.o.
Bionatur sp. z o.o. + limited partnership
Symbio-Lab sp. z o.o.
Tifarm sp. z o.o.
KE Pharma Spółka z Ograniczoną Odpowiedzialością sp. z o.o.

Change history

DateEvent
2026-03-20Address change
2026-03-20Share capital increase
2026-03-20Name change
2026-03-20PKD change
2023-05-31Entered in the register

FAQ

Last updated: 2026-07-30